the low minimal inhibitory concentrations and minimal bactericidal concentrations of the quinolones for most pathogenic gram-negative and many gram-positive organisms , the ease of their administration , and their good oral absorption make them good candidates for the treatment of chronic bone infections .
C0450254
pathogenic
C0029235
organisms